Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Conventional Lead Opposed to Novel ECG (CLONE)

NCT: NCT07624435 · ACTIVE_NOT_RECRUITING

NCT IDNCT07624435
StatusACTIVE_NOT_RECRUITING
Start Date2026-02-18
Completion2026-08
SponsorHelpWear Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

To blindly assess, beat-by-beat, standard ECG intervals (QRS intervals, PQ intervals, and P wave durations) of paired standard lead v4 with paired HeartWatch signals over 20 to 30 seconds of noise-free data.

Frequently Asked Questions

What is Conventional Lead Opposed to Novel ECG (CLONE)?

Conventional Lead Opposed to Novel ECG (CLONE) is a clinical trial registered under NCT07624435. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT07624435?

The current status of NCT07624435 (Conventional Lead Opposed to Novel ECG (CLONE)) is: ACTIVE_NOT_RECRUITING.

When did Conventional Lead Opposed to Novel ECG (CLONE) start?

Conventional Lead Opposed to Novel ECG (CLONE) started on 2026-02-18.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.